FDA Clearance Tracker · P100047-S221
HEARTWARE VENTRICULAR ASSIST SYSTEM
Last checked: Nov 20, 2026Latest source record: Nov 25, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 25, 2024
Approved
Time to decision
88 days
Received Aug 29, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100047-S221
- Device name
- HEARTWARE VENTRICULAR ASSIST SYSTEM
- Applicant
- Medtronic
- Applicant location
- Mounds View, MN
- Received
- Aug 29, 2024
- Decided
- Nov 25, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P100047
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
approval for updating the minimum joint torque strength limits against disassembly torque for the power and serial ports on the HVAD controller
Source documents
Other decisions for Medtronic
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262716 · Decided Nov 6, 2026 · 98 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.